Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids
Tao Tan(Anhui Medical University), Oliver M. Sieber(The University of Melbourne)
Cited by 11
Related Papers
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells
|Cancer Discovery|2023|91
Low-viscosity matrix suspension culture enables scalable analysis of patient-derived organoids and tumoroids from the large intestine
|Communications Biology|2021|45
PI3Kα Translocation Mediates Nuclear PtdIns(3,4,5)P3 Effector Signaling in Colorectal Cancer
|Molecular & Cellular Proteomics|2023|8
Breviscapine alleviates MPP+-induced damage and apoptosis of SH-SY5Y cells by activating Nrf2 pathway
|Tropical Journal of Pharmaceutical Research|2022|0